Dynamic in vitro hemocompatibility testing of poly(ether imide) membranes functionalized with linear, methylated oligoglycerol and oligo(ethylene glycol)

Clinical Hemorheology and Microcirculation

Volumn 54, Issue 3, 2013, Pages 235-248

  Braune, Steffen ^a   Von Ruesten Lange, Maik ^a   Mrowietz, Christof ^a   Lützow, Karola ^a,b   Roch, Toralf ^a,b   Neffe, Axel T ^a,b   Lendlein, Andreas ^a,b   Jung, Friedrich ^a,b  

^a INSTITUTE OF MATERIALS RESEARCH   (Germany)

^b Helmholtz Virtual Institute   (Germany)

Author keywords

biomaterial; hemocompatibility; membranes; Oligoglycerol; protein resistance; surface functionalization

Indexed keywords

BIOMATERIAL; OLIGO(ETHYLENE GLYCOL); OLIGOGLYCEROL; OLIGOMER; PLASMA PROTEIN; POLY(ETHER IMIDE); UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BLOOD COMPATIBILITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FLOW KINETICS; HUMAN; HUMAN CELL; IN VITRO STUDY; METHYLATION; SCREENING; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA;

BIOCOMPATIBLE MATERIALS; BLOOD COAGULATION; BLOOD PLATELETS; COMPLEMENT ACTIVATION; GLYCEROL; HUMANS; MATERIALS TESTING; MEMBRANES, ARTIFICIAL; METHYLATION; PLATELET ACTIVATION; POLYETHYLENE GLYCOLS; POLYMERS; SURFACE PROPERTIES;

EID: 84880530616     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-131729     Document Type: Article

References (67)

1. C.S. Abrams, N. Ellison, A.Z. Budzynski and S.J. Shattil, Direct detection of activated platelets and platelet-derived microparticles in humans, Blood 75 (1990), 128-138
2. C. Abrams and S.J. Shattil, Immunological detection of activated platelets in clinical disorders, Thromb Haemost 65 (1991), 467-473
3. American National Standard, Biological Evaluation-Part 4: Selection of tests for interaction with blood, Association for the Advancement of Medical Instrumentation, Arlington, 2009
4. O.K. Baskurt, M. Boynard, G.C. Cokelet, P. Connes, B.M. Cooke, S. Forconi, F. Liao, et al., New guidelines for hemorheological laboratory techniques, Clin Hemorheol Microcirc 42 (2009), 75-97
5. K.A. Bauer, Activation markers of coagulation, Baillieres Best Pract Res Clin 12 (1999), 387-406
6. B. Berg, H. Solberg, J. Nilsson and N. Tryding, Practical experience in the selection and preparation of reference individuals: Empirical testing of the provisional Scandinavian recommendations, in: Reference values in laboratory medicine, H. Solberg, R. Grasbeck, T. Alstrom, ed., John Wiley & Sons, Chichester (UK), 1981, 55-64
7. P.L. Blackshear, R.J. Forstrom, F.D. Dorman and G.O. Voss, Effect of flow on cells near walls, Fed Proc 30 (1971), 1600-1611
8. M. Blomback, Molecular aspects in clinical hemostasis research at Karolinska Institutet, Biochem Biophys Res Commun 396 (2010), 131-134
9. B. Boneu, G. Bes, H. Pelzer, P. Sie and H. Boccalon, D-Dimers, thrombin antithrombin III complexes and prothrombin fragments 1+2: Diagnostic value in clinically suspected deep vein thrombosis, Thromb Haemost 65 (1991), 28-31
10. K. Breddin, M. Ziemen, O. Bauer,W. Herrmann, L. Schaudinn, U. Schlosser, A.Winterhagen, et al., Time and temperature dependent changes of ADP-and collagen-induced and "spontaneous" aggregation, Thromb Res 19 (1980), 621-638
11. K. Breddin, In-vitro-Methoden zur Beurteilung der Plattchenfunktion, Blut 18 (1968), 84-89
12. K.C. Dee, D.A. Puleo and R. Bizios, Chapter 3. Protein-Surface Interactions, in: An Introduction To Tissue-Biomaterial Interactions, John Wiley & Sons, Inc., New York, USA, 2002
13. K.M. Evans-Nguyen, L.R. Tolles, O. V Gorkun, S.T. Lord and M.H. Schoenfisch, Interactions of thrombin with fibrinogen adsorbed on methyl-, hydroxyl-, amine-, and carboxyl-terminated self-assembled monolayers, Biochemistry 44 (2005), 15561-15568
14. E.J. Favaloro, Clinical utility of the PFA-100, Semin Thromb Hemost 34 (2008), 709-733
15. R.D. Frank, H. Dresbach, H. Thelen and H-G. Sieberth, Glutardialdehyde induced fluorescence technique (GIFT): A new method for the imaging of platelet adhesion on biomaterials, J Biomed Mater Res 52 (2000), 374-381
16. C. Frere, T. Cuisset, J. Quilici, L. Camoin, J. Carvajal, P.E. Morange, M. Lambert, et al., ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome, Thromb Haemost 98 (2007), 838-843
17. G. de Gaetano, C. Cerletti, E. Dejana and R. Latini, Pharmacology of platelet inhibition in humans: Implications of the salicylate-aspirin interaction, Circulation 72 (1985), 1185-1193
18. M. Gawaz, F. Neumann and A. Schomig, Evaluation of platelet membrane glycoproteins in coronary artery disease: Consequences for diagnosis and therapy, Circulation 99 (1999), E1-E11
19. M.B. Gorbet and M. V Sefton, Biomaterial-associated thrombosis: Roles of coagulation factors, complement, platelets and leukocytes, Biomaterials 25 (2004), 5681-5703
20. S. Gordz, C. Mrowietz, G. Pindur, J.W. Park and F. Jung, Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease, Clin Hemorheol Microcirc 32 (2005), 83-87
21. J. Graff, U. Klinkhardt, V.B. Schini-Kerth, S. Harder, N. Franz, S. Bassus and C.M. Kirchmaier, Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor, J Pharmacol Exp Ther 300 (2002), 952-957
22. K.H. Grotemeyer, The platelet-reactivity-test-A useful "by-product" of the blood-sampling procedure? Thrombosis research 61 (1991), 423-431
23. P. Harrison, I. Mackie, A. Mumford, C. Briggs, R. Liesner, M. Winter and S. Machin, Guidelines for the laboratory investigation of heritable disorders of platelet function, Br J Haematol 155 (2011), 30-44
24. S. Hsu-Lin, C.L. Berman, B.C. Furie, D. August and B. Furie, A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets, J Biol Chem 259 (1984), 9121-9126
25. S. Jo and K. Park, Surface modification using silanated poly(ethylene glycol)s, Biomaterials 21 (2000), 605-616
26. F. Jung, R. Bach, C. Mrowietz, U. Seyfert and R.P. Franke, Haemocompatibility of endovascular coronary stents: Wiktor GX., Biomed Tech (Berl) 46 (2001), 200-206
27. F. Jung, C. Mrowietz, U.T. Seyfert, R. Grewe and R.P. Franke, Influence of the direct NO-donor SIN-1 on the interaction between platelets and stainless steel stents under dynamic conditions, Clin Hemorheol Microcirc 28 (2003), 189-199
28. F. Jung, S. Braune and A. Lendlein, Haemocompatibility testing of biomaterials using human platelets, Clin Hemorheol Microcirc 53 (2013), 97-115
29. F. Jung, C.Wischke and A. Lendlein, Degradable, Multifunctional Cardiovascular Implants: Challenges and Hurdles, MRS Bull 35 (2010), 607-613
30. R.K. Kainthan and D.E. Brooks, In vivo biological evaluation of high molecular weight hyperbranched polyglycerols, Biomaterials 28 (2007), 4779-4787
31. R.K. Kainthan, S.R. Hester, E. Levin, D. V Devine and D.E. Brooks, In vitro biological evaluation of high molecular weight hyperbranched polyglycerols, Biomaterials 28 (2007), 4581-4590
32. P. Kingshott, H. Thissen and H.J. Griesser, Effects of cloud-point grafting, chain length, and density of PEG layers on competitive adsorption of ocular proteins, Biomaterials 23 (2002), 2043-2056
33. M. Lange, S. Braune, K. Luetzow, K. Richau, N. Scharnagl, M. Weinhart, A.T. Neffe, et al., Surface functionalization of poly(ether imide) membranes with linear, methylated oligoglycerols for reducing thrombogenicity, Macromol Rapid Commun 33 (2012), 1487-1492
34. S. Li and J.J.D. Henry, Nonthrombogenic approaches to cardiovascular bioengineering, Annu Rev Biomed Eng 13 (2011), 451-475
35. J.N. Lindon, G. McManama, L. Kushner, E.W. Merrill and E.W. Salzman, Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? Blood 68 (1986), 355-62
36. P. Menu, J.F. Stoltz and H. Kerdjoudj, Progress in vascular graft substitute, Clin Hemorheol Microcirc 53 (2013), 117-129
37. S. Nagata and M.M. Glovsky, Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation, J Allergy Clin Immunol 80 (1987), 24-32
38. H.K. Nieuwenhuis, J.J. van Oosterhout, E. Rozemuller, F. van Iwaarden and J.J. Sixma, Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation, Blood 70 (1987), 838-845
39. S. Niewiarowski and E. Rogoeczi, Platelet interaction with polymerizing fibrin, J Clin Invest 51 (1972), 685-700
40. B. Nilsson, K.N. Ekdahl, T.E. Mollnes and J.D. Lambris, The role of complement in biomaterial-induced inflammation, Mol Immunol 44 (2007), 82-94
41. A.T. Nurden, Platelets, inflammation and tissue regeneration, Thromb Haemost 105 Suppl (2011), S13-S33
42. J. Papp, B. Sandor, Z. Vamos, D. Botor, A. Toth, M. Rabai, P. Kenyeres, et al., Antiplatelet effect of acetylsalicylic acid, metamizole and their combination-in vitro and in vivo comparisons, Clin Hemorheol Microcirc (2012), DOI: 10.3233/CH-2012-1636
43. J. Papp, P. Kenyeres and K. Toth, Clinical importance of antiplatelet drugs in cardiovascular diseases, Clin Hemorheol Microcirc 53 (2013), 81-96
44. D. Poli, E. Antonucci, G. Ciuti, R. Abbate and D. Prisco, Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal, J Thromb Haemost 6 (2008), 708-710
45. W.H. Reinhart, Platelets in vascular disease, Clin Hemorheol Microcirc 53 (2013), 71-79
46. A.J. Reininger, Coagulation activity of platelets, Hamostaseologie 27 (2007), 247-250
47. D. Ricklin, G. Hajishengallis, K. Yang and J.D. Lambris, Complement: A key system for immune surveillance and homeostasis, Nat Immunol 11 (2010), 785-797
48. C.S. Rinder, H.M. Rinder, B.R. Smith, J.C. Fitch, M.J. Smith, J.B. Tracey, L.A. Matis, et al., Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation, J Clin Invest 96 (1995), 1564-1572
49. T. Roch, J. Cui, K. Kratz, A. Lendlein and F. Jung, Immuno-compatibility of soft hydrophobic poly (n-butyl acrylate) networks with elastic moduli for regeneration of functional tissues, Clin Hemorheol Microcirc 50 (2012), 131-142
50. A. Ruf and H. Patscheke, Flow cytometric detection of activated platelets: Comparison of determining shape change, fibrinogen binding, and P-selectin expression, Semin Thromb Hemost 21 (1995), 146-151
51. H. Schmid-Schonbein, H. Rieger and T. Fischer, Blood Fluidity as a Consequence of Red Cell Fluidity: Flow Properties of Blood and Flow Behavior of Blood in Vascular Diseases, Angiology 31 (1980), 301-319
52. S.J. Shattil, M. Cunningham and J.A. Hoxie, Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry, Blood 70 (1987), 307-315
53. S.J. Shattil, J.A. Hoxie, M. Cunningham and L.F. Brass, Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation, J Biol Chem 260 (1985), 11107-11114
54. E. Shiba, J.N. Lindon, L. Kushner, G.R. Matsueda, J. Hawiger, M. Kloczewiak, B. Kudryk, et al., Antibody-detectable changes in fibrinogen adsorption affecting platelet activation on polymer surfaces, Am J Physiol 260 (1991), C965-C974
55. B. Sivaraman and R. Latour, The adherence of platelets to adsorbed albumin by receptor-mediated recognition of binding sites exposed by adsorption-induced unfolding, Biomaterials 31 (2010), 1036-1044
56. B. Sivaraman and R. a Latour, The relationship between platelet adhesion on surfaces and the structure versus the amount of adsorbed fibrinogen, Biomaterials 31 (2010), 832-839
57. C. Sperling,M.Fischer,M.F. Maitz and C.Werner, Biomaterials Blood coagulation on biomaterials requires the combination of distinct activation processes, Biomaterials 30 (2009), 4447-4456
58. S. Sun, Y. Yue, X. Huang and D. Meng, Protein adsorption on blood-contact membranes, J Memb Sci 222 (2003), 3-18
59. P. Thevenot, W. Hu and L. Tang, Surface chemistry influences implant biocompatibility, Curr Top Med Chem 8 (2008), 270-280
60. W-B. Tsai, J.M. Grunkemeier and T. a Horbett, Variations in the ability of adsorbed fibrinogen to mediate platelet adhesion to polystyrene-based materials: A multivariate statistical analysis of antibody binding to the platelet binding sites of fibrinogen, Biomed Mater Res A 67 (2003), 1255-1268
61. N. Vene, A. Mavri, K. Kosmelj and M. Stegnar, High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy, Thromb Haemost 90 (2003), 1163-1172
62. L. Vroman, The life of an artificial device in contact with blood: Initial events and their effect on its final state, Bull N Y Acad Med 64 (1988), 352-357
63. M.Weinhart, I. Grunwald, M.Wyszogrodzka, L. Gaetjen, A. Hartwig and R. Haag, Linear poly(methyl glycerol) and linear polyglycerol as potent protein and cell resistant alternatives to poly(ethylene glycol), Chem Asian J 5 (2010), 1992-2000
64. World Medical Association, Declaration of Helsinki: Ethical principles for medical research involving human subjects, J Int Bioethique 15 (2004), 124-129
65. K.K. Wu and J.C. Hoak, A new method for the quantitative determination of platelet aggregates in patients with arterial insufficiency, The Lancet 304 (1974), 924-926
66. M. Yaseen, X. Zhao, A. Freund, A.M. Seifalian and J.R. Lu, Surface structural conformations of fibrinogen polypeptides for improved biocompatibility, Biomaterials 31 (2010), 3781-3792
67. P.M. van der Zee, E. Biro, Y. Ko, R.J. de Winter, C.E. Hack, A. Sturk and R. Nieuwland, P-selectin-and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction, Clin chem 52 (2006), 657-664.